AINDEX
Markets

ENDRA Life Sciences Inc. (NDRA)

NDRANASDAQ-CMBiotechnology: Electromedical & Electrotherapeutic Apparatus

$4.84

+0.0550 (+1.15%) today

Closed, Nov 9, 4:00 PM ET

+1.15% 1D
Market cap
$7.26m
P/E
–
EPS, last 4 quarters
$-5.71
Dividend yield
–
Day range
–
52-week range
$2.96 to $6.95
Average volume
34.3k
Previous close
$4.79

Earnings

next estimate $-0.8400

Next report Nov 13, 2026

Sep 2025

+10.3%

Dec 2025

-35.8%

Mar 2026

-35.0%

Jun 2026

+25.0%

estimate reported, and the surprise

Financials

QuarterSep 2025Dec 2025Mar 2026Jun 2026
Revenue––––
Gross profit––––
Operating income-$1.37m-$1.62m-$2.17m-$1.48m
Net income-$1.60m-$3.17m-$1.31m$160.0k

News

7 latest

The company

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to assess tissue fat content and monitor tissue ablation during minimally invasive procedures, at the point of patient care. TAEUS® is focused on the measurement of fat in the liver as a means to assess and monitor steatotic liver disease and metabolic dysfunction-associated steatohepatitis, chronic liver conditions that affect over two billion people globally, and for which there are no practical diagnostic tools.

Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
NASDAQ-CM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

ENDRA Life Sciences Inc. (NDRA) price, chart and news · AINDEX